Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc (BRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 26,227
  • Shares Outstanding, K 1,639,203
  • Annual Sales, $ 110 K
  • Annual Income, $ -12,520 K
  • 60-Month Beta 91.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BRTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/06/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0093 +70.97%
on 01/26/21
0.0330 -51.82%
on 02/09/21
+0.0064 (+67.37%)
since 01/25/21
3-Month
0.0047 +238.30%
on 12/21/20
0.0330 -51.82%
on 02/09/21
unch (unch)
since 11/25/20
52-Week
0.0001 +15,800.00%
on 08/03/20
0.0464 -65.73%
on 10/29/20
+0.0157 (+7,850.00%)
since 02/25/20

Most Recent Stories

More News
BioRestorative Therapies Provides End of Year Shareholder Letter

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced the following letter from its Chief Executive...

BRTX : 0.0160 (unch)
BioRestorative Therapies Emerges from Chapter 11 Reorganization

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced today that its amended joint plan of reorganization...

BRTX : 0.0160 (unch)
BioRestorative Therapies Featured in IEEE Pulse Magazine's Cover Story About Stem Cell Therapies for Low Back Pain

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced today feature coverage in the news outlet, IEEE Pulse,...

BRTX : 0.0160 (unch)
BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Israeli Patent Office has issued BioRestorative...

BRTX : 0.0160 (unch)
BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Australia Patent Office has issued a Certificate of Grant...

BRTX : 0.0160 (unch)
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a member of the Company's Scientific Advisory Board and its...

BRTX : 0.0160 (unch)
BioRestorative Therapies Comments on Recent Promotional Activity

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on recent promotional activity concerning its shares of...

OTCM : 38.3500 (+0.39%)
BRTX : 0.0160 (unch)
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has expanded its "off-the-shelf" brown adipose derived...

BRTX : 0.0160 (unch)
BioRestorative Therapies' Stockholders Approve Institutional Investor Agreement and Exchange Agreements

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at a special meeting of stockholders, the Company's stockholders...

BRTX : 0.0160 (unch)
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has entered into a securities purchase agreement with Arena...

BRTX : 0.0160 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0183
2nd Resistance Point 0.0177
1st Resistance Point 0.0168
Last Price 0.0160
1st Support Level 0.0153
2nd Support Level 0.0147
3rd Support Level 0.0138

See More

52-Week High 0.0464
Fibonacci 61.8% 0.0287
Fibonacci 50% 0.0233
Fibonacci 38.2% 0.0178
Last Price 0.0160
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar